V. Conclusion, Il s'agit de la première étude qui utilise la technique simplifiée d'anticoagulation régionale avec un dialysat sans calcium en centre d'hémodialyse chronique. Cette nouvelle technique est aussi efficace que l'héparine en termes d'efficacité et de tolérance

, Pour l'instant réservée aux patients avec une contre-indication à l'anticoagulation, elle pourrait se généraliser à tous les patients en hémodialyse chronique. Cette technique pourrait être améliorée en utilisant un dialysat sans acide pour améliorer la biocompatibilité

M. Lassalle, E. Monnet, C. Ayav, J. Hogan, O. Moranne et al., Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry, Transpl Int. sept, vol.32, issue.9, p.902, 2017.

J. C. Hornberger, M. Chernew, J. Petersen, and A. M. Garber, A multivariate analysis of mortality and hospital admissions with high-flux dialysis, J Am Soc Nephrol. déc, vol.3, issue.6, pp.1227-1264, 1992.

Y. Koda, S. Nishi, S. Miyazaki, S. Haginoshita, T. Sakurabayashi et al., Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients, Kidney Int, vol.52, issue.4, pp.1096-101, 1997.

O. Sy, N. Rolin, and M. Monchi, Anticoagulation en épuration extrarénale, Réanimation. juill, vol.18, issue.5, pp.376-84, 2009.

M. Skagerlind and B. G. Stegmayr, An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis, Eur J Clin Pharmacol. mars, vol.74, issue.3, p.74, 2018.

M. Joannidis and H. M. Oudemans-van-straaten, Clinical review: Patency of the circuit in continuous renal replacement therapy, Crit Care, vol.11, issue.4, p.218, 2007.

M. W. Cutts, A. N. Thomas, and R. Kishen, Transfusion requirements during continuous venovenous haemofiltration: -the importance of filter life, Intensive Care Med. nov, vol.26, issue.11, pp.1694-1701, 2000.

R. Rajgopal, M. Bear, M. K. Butcher, and S. G. Shaughnessy, The effects of heparin and low molecular weight heparins on bone, Thromb Res, vol.122, issue.3, pp.293-301, 2008.

P. T. Murray and M. J. Hursting, Heparin-Induced Thrombocytopenia in Patients Administered Heparin Solely for Hemodialysis, Renal Failure. janv, vol.28, issue.7, p.9, 2006.

W. Lim, D. J. Cook, and M. A. Crowther, Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials, J Am Soc Nephrol. déc, vol.15, issue.12, pp.3192-206, 2004.

H. H. Lazrak, E. René, N. Elftouh, and J. Lafrance, Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study, Can J Kidney Health Dis, vol.5, p.2054358118792010, 2018.

L. Melgaard, T. F. Overvad, F. Skjøth, J. H. Christensen, T. B. Larsen et al., Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study, ESC Heart Fail, vol.5, issue.2, pp.319-345, 2018.

J. Van-de-wetering, R. G. Westendorp, J. G. Van-der-hoeven, B. Stolk, J. D. Feuth et al., Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage, J Am Soc Nephrol. janv, vol.7, issue.1, pp.145-50, 1996.

C. Ridel, L. Mercadal, B. Béné, A. Hamani, G. Deray et al., Regional citrate anticoagulation during hemodialysis: a simplified procedure using Duocart biofiltration, Blood Purif, vol.23, issue.6, p.80, 2005.

M. J. Janssen and J. Van-der-meulen, The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients, Neth J Med. mai, vol.48, issue.5, 1996.

P. Evenepoel, B. Maes, J. Vanwalleghem, D. Kuypers, T. Messiaen et al., Regional citrate anticoagulation for hemodialysis using a conventional calciumcontaining dialysate, Am J Kidney Dis. févr, vol.39, issue.2, pp.315-338, 2002.

R. Apsner, H. Buchmayer, T. Lang, B. Unver, W. Speiser et al., Simplified citrate anticoagulation for high-flux hemodialysis, Am J Kidney Dis, vol.38, issue.5, pp.979-87, 2001.

S. Hussain, A. N. Siddiqui, H. Baxi, A. Habib, M. S. Hussain et al., Warfarin use increases bleeding risk in hemodialysis patients with atrial fibrillation: A meta-analysis of cohort studies, J Gastroenterol Hepatol. juin, vol.34, issue.6, pp.975-84, 2019.

S. M. Bagshaw, K. B. Laupland, P. Boiteau, and T. Godinez-luna, Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system, J Crit Care. juin, vol.20, issue.2, p.61, 2005.

M. Monchi, D. Berghmans, D. Ledoux, J. Canivet, B. Dubois et al., Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study, Intensive Care Med. févr, vol.30, issue.2, p.5, 2004.

P. Evenepoel, T. Dejagere, P. Verhamme, K. Claes, D. Kuypers et al., Heparincoated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding, Am J Kidney Dis. mai, vol.49, issue.5, pp.642-651, 2007.

R. F. Singer, O. Williams, C. Mercado, B. Chen, G. Talaulikar et al., Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care, Can J Kidney Health Dis, vol.3, p.22, 2016.

A. G. Schneider, D. Journois, and T. Rimmelé, Complications of regional citrate anticoagulation: accumulation or overload? Crit Care, vol.21, p.281, 2017.

H. U. Meier-kriesche, K. W. Finkel, J. J. Gitomer, and T. D. Dubose, Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation, Am J Kidney Dis. avr, vol.33, issue.4, p.8, 1999.

S. P. Kelleher and G. Schulman, Severe metabolic alkalosis complicating regional citrate hemodialysis, Am J Kidney Dis. mars, vol.9, issue.3, pp.235-241, 1987.

T. Robert, C. Bureau, L. Lebourg, E. Rondeau, T. Petitclerc et al., A simple and novel technique for regional citrate anticoagulation during intermittent hemodialysis may obviate the need for calcium monitoring, Intensive Care Med, vol.43, issue.12, 2017.

S. Faguer, M. Saint-cricq, M. Nogier, I. Labadens, L. Lavayssiere et al., Heparin-Free Prolonged Intermittent Hemodialysis Using Calcium-Free Citrate Dialysate in Critically Ill Patients, Crit Care Med. nov, vol.45, issue.11, pp.1887-92, 2017.

R. M. Lindsay, B. Bene, N. Goux, A. P. Heidenheim, C. Landgren et al., Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis, Am J Kidney Dis. sept, vol.38, issue.3, pp.565-74, 2001.

T. Petitclerc and B. Coevoet,

, Nephrologie, vol.22, issue.5, pp.191-198, 2001.

T. Petitclerc, Estimation of mass transfer through a hemodialyzer: theoretical approach and clinical applications, Artif Organs. juill, vol.22, issue.7, pp.601-608, 1998.

J. Böhler, P. Schollmeyer, B. Dressel, G. Dobos, and W. H. Hörl, Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation, J Am Soc Nephrol. févr, vol.7, issue.2, p.41, 1996.

J. Gubensek, K. Strobl, S. Harm, R. Weiss, T. Eichhorn et al., Influence of citrate concentration on the activation of blood cells in an in vitro dialysis setup, PLoS ONE, vol.13, issue.6, p.199204, 2018.

P. Richtrova, K. Rulcova, J. Mares, and T. Reischig, Evaluation of three different methods to prevent dialyzer clotting without causing systemic anticoagulation effect, Artif Organs. janv, vol.35, issue.1, pp.83-91, 2011.

M. Gritters, M. Grooteman, M. Schoorl, M. Schoorl, P. Bartels et al., Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis, Nephrol Dial Transplant. janv, vol.21, issue.1, pp.153-162, 2006.

R. Pérez-garcía, R. Chamond, R. De-sequera-ortiz, P. Albalate, M. et al., Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate, Nefrologia. déc, vol.37, issue.6, pp.630-637, 2017.

J. C. Bos, M. P. Grooteman, A. J. Van-houte, M. Schoorl, J. Van-limbeek et al., Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis, Nephrol Dial Transplant. juill, vol.12, issue.7, pp.1387-93, 1997.

S. W. Jung, D. R. Kim, K. S. Cho, J. Seo, H. Moon et al., Effects of Dialysate Acidification With Citrate Versus Acetate on Cell Damage, Uremic Toxin Levels, and Inflammation in Patients Receiving Maintenance Hemodialysis, Am J Kidney Dis. mars, vol.73, issue.3, pp.432-436, 2019.

J. Chanard, S. Lavaud, H. Maheut, I. Kazes, F. Vitry et al., The clinical evaluation of lowdose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane, Nephrol Dial Transplant. juin, vol.23, issue.6, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00333450

V. Brunot, J. Serre, G. Mourad, K. Klouche, and V. Pernin, Heparin-free renal replacement therapy for chronic hemodialyzed patients at high risk for bleeding: a comparison of online predilution hemodiafiltration with conventional hemodialysis, Hemodial Int, vol.22, issue.4, pp.463-73, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01894644

M. Skagerlind and B. Stegmayr, Heparin albumin priming in a clinical setting for hemodialysis patients at risk for bleeding, Hemodial Int, vol.21, issue.2, p.9, 2017.

S. Sagedal, A. Hartmann, K. Osnes, S. Bjørnsen, J. Torremocha et al., Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin, Nephrol Dial Transplant. févr, vol.21, issue.2, pp.444-453, 2006.

S. Morabito, I. Guzzo, A. Solazzo, L. Muzi, R. Luciani et al., Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding, J Nephrol. août, vol.16, issue.4, p.71, 2003.